Krishnan, S.M.; Nordlohne, J.; Dietz, L.; Vakalopoulos, A.; Haning, P.; Hartmann, E.; Seifert, R.; Hüser, J.; Mathar, I.; Sandner, P.
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy. Int. J. Mol. Sci. 2021, 22, 8016.
https://doi.org/10.3390/ijms22158016
AMA Style
Krishnan SM, Nordlohne J, Dietz L, Vakalopoulos A, Haning P, Hartmann E, Seifert R, Hüser J, Mathar I, Sandner P.
Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. 2021; 22(15):8016.
https://doi.org/10.3390/ijms22158016
Chicago/Turabian Style
Krishnan, Shalini Murali, Johannes Nordlohne, Lisa Dietz, Alexandros Vakalopoulos, Petra Haning, Elke Hartmann, Roland Seifert, Jörg Hüser, Ilka Mathar, and Peter Sandner.
2021. "Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy" International Journal of Molecular Sciences 22, no. 15: 8016.
https://doi.org/10.3390/ijms22158016
APA Style
Krishnan, S. M., Nordlohne, J., Dietz, L., Vakalopoulos, A., Haning, P., Hartmann, E., Seifert, R., Hüser, J., Mathar, I., & Sandner, P.
(2021). Assessing the Use of the sGC Stimulator BAY-747, as a Potential Treatment for Duchenne Muscular Dystrophy. International Journal of Molecular Sciences, 22(15), 8016.
https://doi.org/10.3390/ijms22158016